567 related articles for article (PubMed ID: 19620298)
21. Comparison of human polymorphonuclear neutrophil elastase, polymorphonuclear neutrophil cathepsin-G, and alpha 2-macroglobulin levels in healthy and inflamed dental pulps.
Rauschenberger CR; McClanahan SB; Pederson ED; Turner DW; Kaminski EJ
J Endod; 1994 Nov; 20(11):546-50. PubMed ID: 7543925
[TBL] [Abstract][Full Text] [Related]
22. Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin G.
Kaup M; Dassler K; Reineke U; Weise C; Tauber R; Fuchs H
Biol Chem; 2002 Jun; 383(6):1011-20. PubMed ID: 12222675
[TBL] [Abstract][Full Text] [Related]
23. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
24. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis.
Adkison AM; Raptis SZ; Kelley DG; Pham CT
J Clin Invest; 2002 Feb; 109(3):363-71. PubMed ID: 11827996
[TBL] [Abstract][Full Text] [Related]
25. N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant.
Lim JK; Lu W; Hartley O; DeVico AL
J Leukoc Biol; 2006 Dec; 80(6):1395-404. PubMed ID: 16963625
[TBL] [Abstract][Full Text] [Related]
26. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
27. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates.
Attucci S; Korkmaz B; Juliano L; Hazouard E; Girardin C; Brillard-Bourdet M; Réhault S; Anthonioz P; Gauthier F
Biochem J; 2002 Sep; 366(Pt 3):965-70. PubMed ID: 12088507
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice.
Hahn I; Klaus A; Janze AK; Steinwede K; Ding N; Bohling J; Brumshagen C; Serrano H; Gauthier F; Paton JC; Welte T; Maus UA
Infect Immun; 2011 Dec; 79(12):4893-901. PubMed ID: 21911460
[TBL] [Abstract][Full Text] [Related]
29. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G.
Tkalcevic J; Novelli M; Phylactides M; Iredale JP; Segal AW; Roes J
Immunity; 2000 Feb; 12(2):201-10. PubMed ID: 10714686
[TBL] [Abstract][Full Text] [Related]
30. Chemotactic factor inactivators of human granulocytes.
Brozna JP; Senior RM; Kreutzer DL; Ward PA
J Clin Invest; 1977 Dec; 60(6):1280-8. PubMed ID: 334799
[TBL] [Abstract][Full Text] [Related]
31. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Laguna B; Echeverría O; Carcas A; Lubomirov R; Casal J; Prieto J
J Antimicrob Chemother; 2005 May; 55(5):742-7. PubMed ID: 15761068
[TBL] [Abstract][Full Text] [Related]
32. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps.
Beiter K; Wartha F; Albiger B; Normark S; Zychlinsky A; Henriques-Normark B
Curr Biol; 2006 Feb; 16(4):401-7. PubMed ID: 16488875
[TBL] [Abstract][Full Text] [Related]
33. Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytes.
Guckian JC; Christensen GD; Schweinle JE; Fine DP
J Immunol; 1981 Oct; 127(4):1659-65. PubMed ID: 7276577
[No Abstract] [Full Text] [Related]
34. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis.
Anderssen T; Halvorsen H; Bajaj SP; Osterud B
Thromb Haemost; 1993 Sep; 70(3):414-7. PubMed ID: 8259540
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
36. Green fluorescent protein-expressing Escherichia coli as a selective probe for HOCl generation within neutrophils.
Palazzolo AM; Suquet C; Konkel ME; Hurst JK
Biochemistry; 2005 May; 44(18):6910-9. PubMed ID: 15865436
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptors: novel PARtners in innate immunity.
Shpacovitch V; Feld M; Bunnett NW; Steinhoff M
Trends Immunol; 2007 Dec; 28(12):541-50. PubMed ID: 17977790
[TBL] [Abstract][Full Text] [Related]
38. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells.
Barker E; Reisfeld RA
Cancer Res; 1993 Jan; 53(2):362-7. PubMed ID: 8417829
[TBL] [Abstract][Full Text] [Related]
39. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
Ramaha A; Patston PA
Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
[TBL] [Abstract][Full Text] [Related]
40. Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease.
Rubio F; Cooley J; Accurso FJ; Remold-O'Donnell E
Thorax; 2004 Apr; 59(4):318-23. PubMed ID: 15047952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
